GREGORY MARTINEZ: Open Payments
NPI 1578931382 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 8 payments from 6 companies in 2025. Trend: 2023 $2,520 · 2024 $551 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 2 | $259 |
| Dexcom, Inc. | 2 | $135 |
| Novo Nordisk Inc | 1 | $125 |
| Astellas Pharma US Inc | 1 | $125 |
| ABBVIE INC. | 1 | $33 |
| PFIZER INC. | 1 | $19 |
Products named: Korlym, Wegovy, Veozah, DEXCOM G7 GSS (161), QULIPTA, ELIQUIS, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
